TITLE:
Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid

CONDITION:
Osteoporosis

INTERVENTION:
zoledronic acid

SUMMARY:

      The purpose of this study is to assess bone mineral density in patients switching from an
      oral bisphosphonate to zoledronic acid, compared to those staying on the oral
      bisphosphonate.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 45 Years to 79 Years
Criteria:

        Inclusion Criteria:

          -  Post-menopausal women between 45 and 79 years of age

          -  Must be osteopenic/osteoporotic

          -  Treatment with oral bisphosphonate for at least 1 year

        Exclusion Criteria:

          -  Any woman of child bearing potential

          -  Treatment with other bone active agents

        Other protocol-defined inclusion/exclusion criteria may apply.
      
